Clinical Trial Update: Clinical Study of an Aluvia-based HAART Regimen for Prevention of Mother-to-child HIV Transmission in Africa [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating an Aluvia (lopinavir/ritonavir)–based HAART regimen for preventing mother-to-child transmission of HIV in Africa has complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Aluvia (lopinavir/ritonavir) (lopinavir/ritonavir)

Snippet

Sponsor: University of Zambia | Conditions: HIV | Phase 4 | Status: COMPLETED